Nordic Capital announces agreement to sell ArisGlobal to Dassault Systèmes, following its transformation into a scaled and AI-enabled life sciences platform

Nordic Capital has announced a definitive agreement to sell ArisGlobal, a prominent provider of software solutions for the life sciences sector, to Dassault Systèmes. The deal, which involves an undisclosed transaction value, marks a full exit for Nordic Capital and is expected to close in the second half of 2026, pending regulatory approvals. This transaction signifies the culmination of a successful partnership that has significantly transformed ArisGlobal into a leading AI-enabled platform within the industry.

Founded in 1989 and headquartered in Waltham, Massachusetts, ArisGlobal has established itself as a key player in the life sciences software market. The company specializes in delivering regulatory, safety, and quality software solutions to a diverse clientele, including major pharmaceutical and biotech organizations, as well as regulatory authorities. ArisGlobal’s flagship offering, the LifeSphere® platform, is a comprehensive, cloud-native suite that integrates various functionalities, enabling clients to manage complex regulatory submissions and pharmacovigilance workflows efficiently. The platform's advanced AI capabilities enhance operational efficiency by automating core processes, thereby improving compliance and accelerating safety case management.

The strategic rationale behind the acquisition lies in the complementary strengths of both companies. ArisGlobal's expertise in AI-enabled safety and regulatory software aligns well with Dassault Systèmes' capabilities across research, clinical development, and manufacturing. This combination is expected to create a more robust, end-to-end offering across the life sciences value chain, addressing the increasing regulatory complexity and data volumes that the industry is currently facing. The partnership will also provide ArisGlobal with enhanced resources and global reach, facilitating further innovation and growth in its product offerings.

Throughout its ownership period, Nordic Capital has played a pivotal role in ArisGlobal's transformation. The firm invested in the company in 2019 and made additional investments in 2021, focusing on modernizing its technology and expanding its market presence. Under Nordic Capital's guidance, ArisGlobal transitioned to a cloud-native architecture and introduced innovative solutions such as NavaX, a generative AI tool designed for safety case processing. This evolution has positioned ArisGlobal as a leader in the application of AI within the life sciences sector, enabling it to serve over 200 enterprise customers, including half of the world's top 50 biopharma companies.

The broader market implications of this transaction are significant, as it highlights a growing trend towards consolidation in the life sciences software sector. As companies navigate increasing regulatory demands and seek to leverage advanced technologies, the integration of capabilities between established players like ArisGlobal and Dassault Systèmes is likely to drive further innovation and efficiency within the industry. This acquisition not only underscores the importance of AI in enhancing compliance workflows but also signals a strategic shift towards comprehensive solutions that can effectively manage regulatory risks in an evolving landscape.